Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
Key Information
Due Date: October 17, 2024
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Cooperative Agreement
Match Required: No
Contact Info:
OERWebmaster03@od.nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
There is a funding opportunity announcement welcoming applications. The purpose of these applications should be to develop, exhibit, and share innovative solutions. These solutions are meant to revolutionize the field of translational science. This can be achieved by tackling inefficiencies that are widespread across various diseases.
Moreover, the initiative focusses on making more interventions available to the public at a quicker pace through scientific collaboration. Collaboration is encouraged among the CTSA Program hubs, NIH Institutes, Centers, Offices (ICOs), and external stakeholders. Notably, having a clinical trial is optional for this competition.
Key Dates
Open Date: May 9, 2022
Application Due Date: October 17, 2024
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- Public and State controlled institutions of higher education